Re-Innovating Dexmedetomidine (RE03) for the Treatment of Insomnia related to Post-traumatic Stress Disorder

Research unit

INNOSUISSE

Project number

119.703 IP-LS

Project title

Re-Innovating Dexmedetomidine (RE03) for the Treatment of stress-induced Insomnia

Texts for this project

	German	French	Italian	English
Key words	-	-	-
Abstract	-	-	-

Category	Text
Key words (English)	Life sciences, Pharmaceuticals
Abstract (English)	Insomnia represents a predisposing, perpetuating and precipitating factor in PTSD. Current sleep medications show poor clinical efficacy, leaving an urgent unmet need. Reconnect is committed to develop an innovative sleep medication to break the vicious cycle of hyperarousal-related insomnia in PTSD